**Core Concept**
N-myc gene amplification is a genetic alteration that involves the amplification of the N-myc gene, a proto-oncogene that plays a crucial role in cell proliferation and differentiation. This amplification is often associated with the development and progression of certain types of cancer, particularly those originating from neuroectodermal tissues.

**Why the Correct Answer is Right**
N-myc gene amplification is a hallmark of neuroblastoma, a malignant tumor of the sympathetic nervous system that predominantly affects children. The amplification of N-myc leads to overexpression of the protein, resulting in uncontrolled cell growth, apoptosis resistance, and poor prognosis. The N-myc protein is involved in the regulation of cell cycle progression, and its overexpression contributes to the malignant transformation of neuroblasts.

**Why Each Wrong Option is Incorrect**
**Option A:** Burkitt's lymphoma is characterized by c-myc gene translocation, not N-myc gene amplification. The c-myc gene translocation leads to the overexpression of the c-myc protein, which contributes to the rapid proliferation of lymphoma cells.

**Option B:** Small cell lung carcinoma is associated with the inactivation of tumor suppressor genes, such as TP53, rather than N-myc gene amplification. The inactivation of TP53 leads to the loss of cell cycle regulation and the accumulation of genetic mutations, contributing to the development of small cell lung carcinoma.

**Clinical Pearl / High-Yield Fact**
Neuroblastoma is a highly heterogeneous tumor, and N-myc gene amplification is a significant prognostic factor. Patients with N-myc amplified neuroblastoma have a poorer prognosis and are more likely to require aggressive treatment, including chemotherapy and radiotherapy.

**Correct Answer Line**
✓ Correct Answer: C. Neuroblastoma